Exchange: NYSEArca·Updated 07:59 PM EDT
LLYX logo

LLYXDefiance Daily Target 2X Long LLY ETF

$27.15
$0.45
(1.69%)
Today
Closed $27.15
$0.05
(0.18%)
After Hours
Vol213,338.00
52W High$29.95
52W Low$9.60
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
<
...
1
>

Advertisement|Remove ads.